JUUL Announces Layoffs and New Funding Amid Challenges

Nov.18.2022
JUUL Announces Layoffs and New Funding Amid Challenges
JUUL announced layoffs and new funding to deal with lawsuits, government bans, and increased competition in the e-cigarette market.

Electronic cigarette brand JUUL announced layoffs of several hundred employees on Thursday, as it copes with lawsuits, government bans, and fierce competition from other e-cigarette brands. JUUL stated that it received new funding to maintain operations, including a challenging plan to challenge the FDA's ban on its products. According to sources, the layoffs include 400 employees, which is part of JUUL's plan to cut its operational budget by 30% to 40%, with details kept anonymous. The new funding reportedly comes from two early JUUL investors: Nicholas Pritzker from Hyatt Hotels and private equity expert Riaz Valani from San Francisco. In recent weeks, analysts speculated that JUUL may soon declare bankruptcy or sell itself to another company. However, Thursday's announcement delayed the next steps in this direction. A JUUL spokesperson stated in an email that "this investment will enable JUUL Labs to maintain business operations, advance its appeal of the FDA's premarket tobacco product application decisions, and support product innovation and scientific research." Five years ago, JUUL became the leading brand in the US e-cigarette market due to the popularity of flavors like mango, mint, and crème brûlée. However, the company's rise was driven by the use of teenagers, some of whom became addicted to JUUL's high-nicotine pods. Strong opposition to teenage e-cigarette use led to a series of government actions forcing the company to gradually exit the market. Since 2019, JUUL has abandoned all US advertising and discontinued most flavors. The biggest blow came in June when the FDA denied the company's application to keep its products on the market as an alternative to adult smoking, putting JUUL's future in uncertainty. The FDA stated that JUUL did not adequately address key issues regarding possible chemical leaks from its device. During JUUL's appeal, the FDA temporarily suspended its initial decision. Another setback occurred in September when the company's largest investor, tobacco giant Altria, announced plans to re-enter the e-cigarette market. After acquiring nearly $13 billion worth of JUUL's shares, Altria withdrew its own e-cigarette from the market in 2018. But with JUUL's declining prospects, the investment has lost more than 95% of its value, leading Altria to exit its non-compete agreement. This decision means that JUUL will soon be forced to compete with Altria, the maker of Marlboro, and long-time rival Vuse from Reynolds American for retail shelf space. Vuse recently surpassed JUUL to become the leading e-cigarette brand in the US. JUUL's share of this $5.5 billion retail market has dropped from a peak of 75% a few years ago to around 33%. While JUUL is no longer popular among US youths, the company remains a target for politicians in Washington and across the US seeking to crack down on teenage e-cigarette use. In September, JUUL announced it will pay $440 million to settle investigations into its marketing practices and contribution to the surge in adolescent e-cigarette use across nearly 30 states. But the company still faces nine independent lawsuits from other states. Thousands of individual lawsuits brought by individuals and families have been consolidated in a California federal court.


Statement:


This article is compiled from third-party information and is provided for industry-related discussions and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is solely intended for communication and research within the industry.


Due to limitations in our ability to accurately translate, this article may not perfectly reflect the wording of the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong/Macau/Taiwan-related, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
A 28-year-old man in Singapore was sentenced on Jan 22 after admitting to six offences spanning 2021 to 2024, including possessing vapes and vape pods for sale.
Jan.23 by 2FIRSTS.ai
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco (JT) said it has applied to raise retail prices for its heated tobacco-related products from April 1, 2026, covering 37 variants of Ploom tobacco sticks and with capsules, with most increases at 20–30 yen per pack (about $0.13–$0.19).
Jan.28 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
Maryland middle school incident: 11-year-olds found with a THC vaping device; juvenile citations issued
Maryland middle school incident: 11-year-olds found with a THC vaping device; juvenile citations issued
The BayNet reports that on Feb. 5 at about 1:35 p.m., an 11-year-old student at Davis Middle School in Waldorf, Maryland, was found in possession of a vaping device containing THC. Further investigation found that two other 11-year-old students also possessed the same vaping device at different points during the day.
Feb.09 by 2FIRSTS.ai
Buenos Aires Province issues health alert over growing use and promotion of nicotine pouches
Buenos Aires Province issues health alert over growing use and promotion of nicotine pouches
The Ministry of Health of the Province of Buenos Aires issued a health alert to the public and health teams over increased circulation, promotion and consumption of nicotine pouches. It said the disposable oral products dissolve in the mouth without combustion or vapor and are marketed as tobacco-free, but contain nicotine and have a high addictive potential.
Jan.13 by 2FIRSTS.ai